Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Epstein

Showing results (571-580 of 635) with videos related to

Pageof 64
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
Histopathology|October 10, 2013
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmapsEva Compérat, Lars Egevad, Antonio Lopez-Beltran, et al.
The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
The American Journal of Surgical Pathology|July 16, 2014
Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conferenceMahul B Amin, Jonathan I Epstein, Thomas M Ulbright, et al.
American Journal of Clinical Pathology|February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancersOleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.
Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Pageof 64

Showing results (571-580 of 635) with videos related to

Sort By:
Pageof 64
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2020
Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinomaChen Yang, Robert S Cimera, Ruth Aryeequaye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome]Johannes Giedl, Peter J Wild, Robert Stoehr, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
Histopathology|October 10, 2013
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmapsEva Compérat, Lars Egevad, Antonio Lopez-Beltran, et al.
The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.
The American Journal of Surgical Pathology|July 16, 2014
Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conferenceMahul B Amin, Jonathan I Epstein, Thomas M Ulbright, et al.
American Journal of Clinical Pathology|February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancersOleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.
Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Pageof 64